These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 12945721)

  • 21. Antibodies to fibrin-bound tissue-type plasminogen activator in systemic lupus erythematosus are associated with Raynaud's phenomenon and thrombosis.
    Salazar-Paramo M; Garcia de la Torre I; Fritzler MJ; Loyau S; Anglés-Cano E
    Lupus; 1996 Aug; 5(4):275-8. PubMed ID: 8869898
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The autoimmune response to chromatin antigens in systemic lupus erythematosus: autoantibodies against histone H1 are a highly specific marker for SLE associated with increased disease activity.
    Schett G; Smole J; Zimmermann C; Hiesberger H; Hoefler E; Fournel S; Muller S; Rubin RL; Steiner G
    Lupus; 2002; 11(11):704-15. PubMed ID: 12475000
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circulating anti-double-stranded DNA antibody-secreting cells in patients with systemic lupus erythematosus: a novel biomarker for disease activity.
    Hanaoka H; Okazaki Y; Satoh T; Kaneko Y; Yasuoka H; Seta N; Kuwana M
    Lupus; 2012 Oct; 21(12):1284-93. PubMed ID: 22740429
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlation between anti-Ro/La titers and clinical findings of patients with systemic lupus erythematosus.
    Chien JW; Lin CY; Yang LY
    Zhonghua Yi Xue Za Zhi (Taipei); 2001 May; 64(5):283-91. PubMed ID: 11499338
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protein array autoantibody profiles for insights into systemic lupus erythematosus and incomplete lupus syndromes.
    Li QZ; Zhou J; Wandstrat AE; Carr-Johnson F; Branch V; Karp DR; Mohan C; Wakeland EK; Olsen NJ
    Clin Exp Immunol; 2007 Jan; 147(1):60-70. PubMed ID: 17177964
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ASE-1: an autoantigen in systemic lupus erythematosus.
    Edworthy S; Fritzler M; Whitehead C; Martin L; Rattner JB
    Lupus; 2000; 9(9):681-7. PubMed ID: 11199923
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-C1q autoantibodies in lupus nephritis: prevalence and clinical significance.
    Sinico RA; Radice A; Ikehata M; Giammarresi G; Corace C; Arrigo G; Bollini B; Li Vecchi M
    Ann N Y Acad Sci; 2005 Jun; 1050():193-200. PubMed ID: 16014534
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High prevalence of autoantibodies against the nuclear high mobility group (HMG) protein SSRP1 in sera from patients with systemic lupus erythematosus, but not other rheumatic diseases.
    Santoro P; De Andrea M; Migliaretti G; Trapani C; Landolfo S; Gariglio M
    J Rheumatol; 2002 Jan; 29(1):90-3. PubMed ID: 11824977
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The clinical significance of autoantibodies to soluble cellular antigens in systemic lupus erythematosus.
    Asero R; Bertetti E; Origgi L; Riboldi P; Zanussi C
    J Clin Lab Immunol; 1990 Mar; 31(3):115-9. PubMed ID: 1966995
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selective adsorption of antiphospholipid and anti-dsDNA autoantibodies on histidine based pseudobioaffinity adsorbent from sera of patients with systemic lupus erythematosus (SLE).
    Zeinab M; Hiam KM; Edmond C; Assem E
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Jan; 975():77-83. PubMed ID: 25438246
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between anti-Sm and anti-ribosomal P protein autoantibodies in human systemic lupus erythematosus and MRL/lpr mice.
    Elkon KB; Bonfa E; Llovet R; Eisenberg RA
    J Immunol; 1989 Sep; 143(5):1549-54. PubMed ID: 2760462
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autoantibodies against eukaryotic protein L7 in patients suffering from systemic lupus erythematosus and progressive systemic sclerosis: frequency and correlation with clinical, serological and genetic parameters. The SLE Study Group.
    Neu E; von Mikecz AH; Hemmerich PH; Peter HH; Fricke M; Deicher H; Genth E; Krawinkel U
    Clin Exp Immunol; 1995 May; 100(2):198-204. PubMed ID: 7743655
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibodies to new cytoplasmic autoantigens: anti-JA, a potential marker for disease activity in systemic lupus erythematosus.
    Bonfa E; Tavares AV; Viana VS; Levy-Neto M; Kumeda CA; Cossermelli W
    Braz J Med Biol Res; 1992; 25(6):601-9. PubMed ID: 1342236
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement.
    Oelzner P; Deliyska B; Fünfstück R; Hein G; Herrmann D; Stein G
    Clin Rheumatol; 2003 Oct; 22(4-5):271-8. PubMed ID: 14576989
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased prevalence of transfusion-transmitted virus and cross-reactivity with immunodominant epitopes of the HRES-1/p28 endogenous retroviral autoantigen in patients with systemic lupus erythematosus.
    Gergely P; Pullmann R; Stancato C; Otvos L; Koncz A; Blazsek A; Poor G; Brown KE; Phillips PE; Perl A
    Clin Immunol; 2005 Aug; 116(2):124-34. PubMed ID: 15894513
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Measurement of autoantibodies in pediatric-onset systemic lupus erythematosus and their relationship with disease-associated manifestations.
    Gilliam BE; Ombrello AK; Burlingame RW; Pepmueller PH; Moore TL
    Semin Arthritis Rheum; 2012 Jun; 41(6):840-8. PubMed ID: 22177108
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibody against chromatin assembly factor-1 is a novel autoantibody specifically recognized in systemic lupus erythematosus.
    Doe K; Nozawa K; Hiruma K; Yamada Y; Matsuki Y; Nakano S; Ogasawara M; Nakano H; Ikeda T; Ikegami T; Fujishiro M; Kawasaki M; Ikeda K; Amano H; Morimoto S; Ogawa H; Takamori K; Sekigawa I; Takasaki Y
    Lupus; 2014 Sep; 23(10):1031-41. PubMed ID: 24836587
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sensitivity and specificity of ANA and anti-dsDNA in the diagnosis of systemic lupus erythematosus: a comparison using control sera obtained from healthy individuals and patients with multiple medical problems.
    Wichainun R; Kasitanon N; Wangkaew S; Hongsongkiat S; Sukitawut W; Louthrenoo W
    Asian Pac J Allergy Immunol; 2013 Dec; 31(4):292-8. PubMed ID: 24383972
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Prevalence of autoantibodies directed against 1,25(OH)2D3 in patients with systemic lupus erythematosus].
    Bogaczewicz J; Sysa-Jedrzejowska A; Arkuszewska C; Zabek J; Kontny E; Wozniacka A
    Pol Merkur Lekarski; 2010 Feb; 28(164):103-7. PubMed ID: 20369736
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of autoantibodies to ribosomal P proteins in juvenile-onset systemic lupus erythematosus compared with the adult disease.
    Reichlin M; Broyles TF; Hubscher O; James J; Lehman TA; Palermo R; Stafford HA; Taylor-Albert E; Wolfson-Reichlin M
    Arthritis Rheum; 1999 Jan; 42(1):69-75. PubMed ID: 9920016
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.